Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate Gel 0.06% Dose-Finding for Actinic Keratosis
NCT01998984Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Jan 2014
- Primary completion
- Jul 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in actinic keratosis (AK), sponsored by LEO Pharma. Started Jan 2014; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01998984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998984.